Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.

KVUE's Q2 sales and earnings miss estimates, but organic growth improved as Skin Health and Beauty led a broader recovery.

MED's improving coach productivity and client retention point to stabilization, but a shrinking coach base remains a challenge.

Medifast’s second quarter was marked by stabilization in key business metrics despite continued pressure from declining coach numbers and shifting industry trends. The company’s revenue and earnings surpassed Wall Street expectations, contributing to a strong positive market reaction. Management credited improved coach productivity—up for the third consecutive quarter—and the early impact of its new consumer brand, Trilivy, as key drivers of sequential stabilization. CEO Nick Johnson highlighted

DOLE's Q2 earnings miss estimates as higher fruit sourcing, fuel and shipping costs pressured Fresh Fruit, despite strong Americas growth.

Coach count plummeted 48.7%, yet management targets profitability by Q4 2026.

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.

Medifast's Trilivy launch and cost cuts could support a Q4 profit turnaround, but shrinking revenue and its coach base keep risks high.

Medifast stock gains 13.6% in a month as improving coach productivity and earnings expectations support momentum despite weaker revenue.

Medifast's low valuation and improving coach productivity offer potential, but a shrinking coach base and weak growth keep the turnaround high risk.

PRMB beats second-quarter earnings and sales estimates, fueled by spring and premium water, and raises its 2026 sales growth outlook.

ADM adjusted earnings nearly double in the second quarter as oilseeds, ethanol and Nutrition gains fuel a raised 2026 outlook.

MED tops Q2 earnings expectations despite lower sales, as rising coach productivity helps offset pressure from a shrinking coach network.

Moby summary of Medifast, Inc.'s Q2 2026 earnings call

Medifast Inc (MED) navigates a 27.6% revenue drop while boosting coach productivity 41% and launching its Trilivy brand to target metabolic health and return to profitability by Q4 2026.

Medifast (NYSE:MED) reported second-quarter 2026 revenue of $76.4 million, down 27.6% from a year earlier, as its active earning coach base continued to decline amid the rapid adoption of GLP-1 medications across the traditional weight-loss category. The company posted a net loss of $3.1 million, or

Medifast (MED) delivered earnings and revenue surprises of +58.21% and +1.14%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Wellness company Medifast (NYSE:MED) reported Q2 CY2026 results topping the market’s revenue expectations, but sales fell by 27.6% year on year to $76.38 million. On top of that, next quarter’s revenue guidance ($70 million at the midpoint) was surprisingly good and 3.4% above what analysts were expecting. Its GAAP loss of $0.28 per share was 56.9% above analysts’ consensus estimates.

Wellness company Medifast (NYSE:MED) will be reporting results this Monday after market hours. Here’s what you need to know.

CL's Q2 earnings beat as organic sales, productivity and margin gains offset higher brand investment, while Latin America led regional growth.

PG's Q4 earnings beat estimates as productivity savings offset cost pressures, while flat organic sales and modest fiscal 2027 guidance temper the outlook.

MED's Q2 results are likely to face continued pressure from GLP-1 adoption and a smaller coach base, while productivity gains and cost actions may have helped offset some challenges.

BellRing Brands (BRBR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Medifast (MED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The past year hasn’t been kind to the stocks featured in this article. Each has tumbled to its lowest point in 12 months, leaving investors to decide whether they’re witnessing fire sales or falling knives.

COCO's strong Q2 beat, higher guidance and the Copra acquisition highlight accelerating momentum in coconut water and private label growth.

POST is repositioning its pet food brands with pricing changes and the Nutrish relaunch to improve volumes and category performance.

KR is simplifying its pricing strategy to strengthen value perception while funding investments through efficiency gains.

TAP is leaning on premium beer, acquisitions and its Horizon 2030 strategy to expand beyond brewing and support long-term growth.

Medifast's Trilivy expands beyond weight management with metabolic health support, personalized coaching and a structured three-phase journey.

Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.

ADM's portfolio optimization, cost-cutting efforts and push into nutrition and value-added products are fueling investor confidence and stock gains.

BF.B is strengthening its premium portfolio and expanding into new categories as innovation and global growth initiatives support its long-term strategy.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Medifast (NYSE:MED) and the best and worst performers in the personal care industry.

KR is raising freshness standards and refining merchandising to strengthen customer loyalty and support long-term growth.